Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Prognostic Impacts of Additional Cytogenetic Abnormalities Acquired at the First Relapse in Adult Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplant in Second Complete Remission

Hiroaki Shimizu, Junichi Mukae, Naoki Shingai, Takashi Toya, Yuho Najima, Takeshi Kobayashi, Nahoko Hatsumi, Satoru Takada, Hiroshi Handa, Kyoko Haraguchi, Yoshiki Okuyama, Hisashi Sakamaki, Kazuteru Ohashi, Noriko Doki

Blood (2021) 138 (Supplement 1): 3380.

https://doi.org/10.1182/blood-2021-152621

Published: 2021

Journal Articles

Extramedullary Relapses after Allogeneic Stem Cell Transplant (allo-SCT) in Adult Patients with Acute Lymphoblastic Leukemia (ALL)

Hiroaki Shimizu, MD PhD, Takuma Ishizaki, MD PhD, Nahoko Hatsumi, MD, Satoru Takada, MD, Akihiko Yokohama, MD PhD, Takayuki Saitoh, MD PhD, Toru Sakura, PhD MD, Hiroshi Handa, MD PhD

Blood (2019) 134 (Supplement_1): 5690.

https://doi.org/10.1182/blood-2019-130590

Published: 2019

Journal Articles

Clinical Significance of Clonal Cytogenetic Heterogeneity (CCH) at Diagnosis in Adult Patients with Acute Lymphoblastic Leukemia (ALL)

Hiroaki Shimizu, MD PhD, Nahoko Hatsumi, MD, Satoru Takada, MD, Takuma Ishizaki, MD PhD, Akihiko Yokohama, MD PhD, Takayuki Saitoh, MD PhD, Toru Sakura, PhD MD, Hiroshi Handa, MD PhD

Blood (2018) 132 (Supplement 1): 2820.

https://doi.org/10.1182/blood-2018-99-118462

Published: 2018

Journal Articles

Clinical Significance of Additional Cytogenetic Abnormalities (ACA) Acquired at the First Relapse in Adult Patients with Philadelphia Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (ALL)

Hiroaki Shimizu, MD PhD, Satoru Takada, MD, Nahoko Hatsumi, MD, Akihiko Yokohama, MD PhD, Takayuki Saitoh, MD PhDProf, Toru Sakura, PhD MD, Hiroshi Handa, MD PhDChief Division

Blood (2017) 130 (Supplement 1): 2716.

https://doi.org/10.1182/blood.V130.Suppl_1.2716.2716

Published: 2017

Journal Articles

Risk Factors and Clinical Impact of Chronic Kidney Disease (CKD) after Allogeneic Stem Cell Transplant (allo-SCT)

Hiroaki Shimizu, Takuma Ishizaki, Nahoko Hatsumi, Satoru Takada, MD, Akihiko Yokohama, MD PhD, Takayuki Saitoh, MD PhD, Yoshihisa Nojima, Hiroshi Handa, MD PhD

Blood (2016) 128 (22): 3440.

https://doi.org/10.1182/blood.V128.22.3440.3440

Published: 2016

Journal Articles

Clinical Significance of Additional Cytogenetic Abnormalities (ACA) Acquired at the First Relapse in Adult Acute Myeloid Leukemia (AML) Patients

Hiroaki Shimizu, MDPhD, Akihiko Yokohama, MD PhD, Nahoko Hatsumi, MD, Satoru Takada, MD, Takayuki Saitoh, MD, PhD, Hiroshi Handa, MD, Toru Sakura, MD PhD, Yoshihisa Nojima, MD PhD

Blood (2014) 124 (21): 3673.

https://doi.org/10.1182/blood.V124.21.3673.3673

Published: 2014

Journal Articles

The Polymorphisms Of Base Excision Repair Genes Influence The Cytogenetic Risk Factors In Acute Myeloid Leukemia

Atsushi Iwasaki, Takayuki Saitoh, M.D. Ph.D., Yasuhiro Nitta, Batchimeg Norjimaa, Chiharu Omiya, Akira Kamiya, Nahoko Hatsumi, M.D., Hiroaki Shimizu, M.D. Ph.D., Takuma Ishizaki, M.D. Ph.D., Takumi Hoshino, Satoru Takada, MD, Hiroshi Handa, MD, PhD, Toru Sakura, MD, PhD, Akihiko Yokohama, MD, PhD, Norifumi Tsukamoto, MD, PhD, Hirokazu Murakami, M.D. Ph.D.

Blood (2013) 122 (21): 1355.

https://doi.org/10.1182/blood.V122.21.1355.1355

Published: 2013

Journal Articles

Clinical Significance of Mixed Phenotype in Adult Patients with Philadelphia Chromosome-Positive Acute Leukemia–no Prognostic Impact in the Imatinib Era.

Hiroaki Shimizu, M.D., Akihiko Yokohama, MD, PhD, Hiroko Koya, M.D., Rumi Shimizu, M.D., Nahoko Hatsumi, M.D., Satoru Takada, MD, Takayuki Saitoh, M.D. Ph.D., Toru Sakura, M.D., Shuichi Miyawaki, MD, Hiroshi Handa, M.D. Ph.D.

Blood (2012) 120 (21): 2574.

https://doi.org/10.1182/blood.V120.21.2574.2574

Published: 2012

Journal Articles

The Efficacy of Time-Sequential Administration of GO After Conventional Chemotherapy for AML

Satoru Takada, M.D., Naru Sato, M.D., Nobuhiko Kobayashi, M.D., Hoshino Takumi, M.D., Nahoko Hatsumi, M.D., Toru Sakura, M.D.

Blood (2012) 120 (21): 4338.

https://doi.org/10.1182/blood.V120.21.4338.4338

Published: 2012

Journal Articles

The Analysis of Patients with Refractoriness to Platelet Transfusion Due to Anti-HLA Antibodies During the Treatment of Acute Leukemia

Satoru Takada, M.D., Hiroko Koya, M.D., Akinori Yuzuriha, M.D., Hiroaki Shimizu, M.D., Nahoko Hatsumi, M.D., Toru Sakura, M.D.

Blood (2011) 118 (21): 4339.

https://doi.org/10.1182/blood.V118.21.4339.4339

Published: 2011

Journal Articles

Gentuzumab Ozogamicin (GO:Mylotarg) Monotherapy for Relapsed AML after Hematopoietic Stem Cell Transplantation: from Morphological Target to Molecular Target.

Shuichi Miyawaki, MD, Nahoko Hatsumi, MD, Takumi Hoshino, MD, Toshihide Kawamura, MD, Satoru Takada, MD, Tohru Sakura, MD

Blood (2007) 110 (11): 5026.

https://doi.org/10.1182/blood.V110.11.5026.5026

Published: 2007

Journal Articles

Prognosis of Acute Myeloid Leukemia with Translocation (8;21): A Survey of 142 Cases Investigated in the JALSG AML97 Study.

Nahoko Hatsumi, Shuichi Miyawaki, MD, PhD, Hisashi Sakamaki, MD, Shigeki Ohtake, MD, Fumiharu Yagaski, MD, Kinuko Mitani, MD, Shin Matsuda, MD, Yuji Kishimoto, MD, Yasushi Miyazaki, MD, Norio Asou, MD, Sumihisa Honda, MD, Masafumi Taniwaki, MD, Ryuzo Ohno, MD

Blood (2005) 106 (11): 4511.

https://doi.org/10.1182/blood.V106.11.4511.4511

Published: 2005

Journal Articles

Prognostic Impact of the Detection of the WT1 Gene mRNA with Peripheral Blood in Adult Acute Myeloid Leukemia (AML).

Shuichi Miyawaki, MD, PhD, Nahoko Hatsumi, Toshiharu Tamaki, MD, Tomoki Naoe, MD, Keiya Ozawa, MD, Kunio Kitamura, MD, Takahiro Karasuno, MD, Kinuko Mitani, MD, Yoshihisa Kodera, MD, Tamotsu Yamagami, MD, Daisuke Koga

Blood (2005) 106 (11): 3289.

https://doi.org/10.1182/blood.V106.11.3289.3289

Published: 2005

NARROW

Prognostic Impacts of Additional Cytogenetic Abnormalities Acquired at the First Relapse in Adult Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplant in Second Complete Remission

Extramedullary Relapses after Allogeneic Stem Cell Transplant (allo-SCT) in Adult Patients with Acute Lymphoblastic Leukemia (ALL)

Clinical Significance of Clonal Cytogenetic Heterogeneity (CCH) at Diagnosis in Adult Patients with Acute Lymphoblastic Leukemia (ALL)

Clinical Significance of Additional Cytogenetic Abnormalities (ACA) Acquired at the First Relapse in Adult Patients with Philadelphia Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (ALL)

Risk Factors and Clinical Impact of Chronic Kidney Disease (CKD) after Allogeneic Stem Cell Transplant (allo-SCT)

Clinical Significance of Additional Cytogenetic Abnormalities (ACA) Acquired at the First Relapse in Adult Acute Myeloid Leukemia (AML) Patients

The Polymorphisms Of Base Excision Repair Genes Influence The Cytogenetic Risk Factors In Acute Myeloid Leukemia

Clinical Significance of Mixed Phenotype in Adult Patients with Philadelphia Chromosome-Positive Acute Leukemia–no Prognostic Impact in the Imatinib Era.

The Efficacy of Time-Sequential Administration of GO After Conventional Chemotherapy for AML

The Analysis of Patients with Refractoriness to Platelet Transfusion Due to Anti-HLA Antibodies During the Treatment of Acute Leukemia

Gentuzumab Ozogamicin (GO:Mylotarg) Monotherapy for Relapsed AML after Hematopoietic Stem Cell Transplantation: from Morphological Target to Molecular Target.

Prognosis of Acute Myeloid Leukemia with Translocation (8;21): A Survey of 142 Cases Investigated in the JALSG AML97 Study.

Prognostic Impact of the Detection of the WT1 Gene mRNA with Peripheral Blood in Adult Acute Myeloid Leukemia (AML).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only